CEBP 09 AM Call for Abstracts w/deadline Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, V. W.
Right arrow Articles by Sobhan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, V. W.
Right arrow Articles by Sobhan, M.

Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 2 127-135, Copyright © 1994 by American Association for Cancer Research


ARTICLES

Histological characteristics of breast carcinoma in blacks and whites

VW Chen, P Correa, RJ Kurman, XC Wu, JW Eley, D Austin, H Muss, CP Hunter, C Redmond and M Sobhan
Department of Pathology, Louisiana State University Medical Center, New Orleans 70112-1393.

Tumor characteristics of 963 newly diagnosed invasive breast cancer cases from the population-based Black/White Cancer Survival Study were evaluated. Representative slides of the tumors were requested from all participating hospitals of three metropolitan areas and reviewed by one expert pathologist, blinded in regard to the age and race of patients. Nine tumor characteristics were evaluated for black and white patients. After adjusting for age, stage, and metropolitan area, blacks were significantly more likely to have high grade nuclear atypia [odds ratio (OR) = 1.97, 95% confidence interval (CI) = 1.27-3.04]; high mitotic activity (OR = 2.05, 95% CI = 1.34-3.14), grade 3 tumors (OR = 1.58, 95% CI = 1.02-2.45), and more necrosis (OR = 1.51, 95% CI = 1.16-1.98); and less likely to have well defined tubular formation (OR = 0.57, 95% CI = 0.42-0.77), marked fibrosis (OR = 0.65, 95% CI = 0.45-0.94), and positive estrogen receptor status (OR = 0.78, 95% CI = 0.58-1.05). These black/white differences remained after controlling for socioeconomic status (SES), body mass index, use of alcohol and tobacco, reproductive experience, and health care access and utilization. No significant racial differences were found for blood vessel invasion and lymphatic invasion. Although white women of high SES had more favorable tumors than those of low SES, the same pattern was not observed for blacks. High SES black women had statistically nonsignificant elevated ORs of a high mitotic index and tumor grade. These racial differences in tumor biology may have etiological and clinical implications.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. R. Smith, S. A. Adams, I. P. Das, M. Bottai, J. Fulton, and J. R. Hebert
Breast Cancer Survival among Economically Disadvantaged Women: The Influences of Delayed Diagnosis and Treatment on Mortality
Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2882 - 2890.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
K. M. E. Hahn, M. L. Bondy, M. Selvan, M. J. Lund, J. M. Liff, E. W. Flagg, L. A. Brinton, P. Porter, J. W. Eley, and R. J. Coates
Factors Associated with Advanced Disease Stage at Diagnosis in a Population-based Study of Patients with Newly Diagnosed Breast Cancer
Am. J. Epidemiol., November 1, 2007; 166(9): 1035 - 1044.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. D. Crew, A. I. Neugut, X. Wang, J. S. Jacobson, V. R. Grann, G. Raptis, and D. L. Hershman
Racial Disparities in Treatment and Survival of Male Breast Cancer
J. Clin. Oncol., March 20, 2007; 25(9): 1089 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Amend, D. Hicks, and C. B. Ambrosone
Breast Cancer in African-American Women: Differences in Tumor Biology from European-American Women.
Cancer Res., September 1, 2006; 66(17): 8327 - 8330.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. Smith-Bindman, D. L. Miglioretti, N. Lurie, L. Abraham, R. B. Barbash, J. Strzelczyk, M. Dignan, W. E. Barlow, C. M. Beasley, and K. Kerlikowske
Does utilization of screening mammography explain racial and ethnic differences in breast cancer?
Ann Intern Med, April 18, 2006; 144(8): 541 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J D Fackenthal, L Sveen, Q Gao, E K Kohlmeir, C Adebamowo, T O Ogundiran, A A Adenipekun, R Oyesegun, O Campbell, C Rotimi, et al.
Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients
J. Med. Genet., March 1, 2005; 42(3): 276 - 281.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
W. McCaskill-Stevens, J. Wilson, J. Bryant, E. Mamounas, L. Garvey, J. James, W. Cronin, and D. L. Wickerham
Contralateral Breast Cancer and Thromboembolic Events in African American Women Treated With Tamoxifen
J Natl Cancer Inst, December 1, 2004; 96(23): 1762 - 1769.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. Schairer, P. J. Mink, L. Carroll, and S. S. Devesa
Probabilities of Death From Breast Cancer and Other Causes Among Female Breast Cancer Patients
J Natl Cancer Inst, September 1, 2004; 96(17): 1311 - 1321.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Banerjee, J. George, E. Y. Song, A. Roy, and W. Hryniuk
Tree-Based Model for Breast Cancer Prognostication
J. Clin. Oncol., July 1, 2004; 22(13): 2567 - 2575.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. F. Kadlubar, G. S. Berkowitz, R. R. Delongchamp, C. Wang, B. L. Green, G. Tang, J. Lamba, E. Schuetz, and M. S. Wolff
The CYP3A4*1B Variant Is Related to the Onset of Puberty, A Known Risk Factor for the Development of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 327 - 331.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. J. Dignam, Y. Ye, L. Colangelo, R. Smith, E. P. Mamounas, H. S. Wieand, and N. Wolmark
Prognosis After Rectal Cancer in Blacks and Whites Participating in Adjuvant Therapy Randomized Trials
J. Clin. Oncol., February 1, 2003; 21(3): 413 - 420.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. I. Li, K. E. Malone, and J. R. Daling
Differences in Breast Cancer Stage, Treatment, and Survival by Race and Ethnicity
Arch Intern Med, January 13, 2003; 163(1): 49 - 56.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
A. Ghafoor, A. Jemal, V. Cokkinides, C. Cardinez, T. Murray, A. Samuels, and M. J. Thun
Cancer Statistics for African Americans
CA Cancer J Clin, November 1, 2002; 52(6): 326 - 341.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. X. Clegg, F. P. Li, B. F. Hankey, K. Chu, and B. K. Edwards
Cancer Survival Among US Whites and Minorities: A SEER (Surveillance, Epidemiology, and End Results) Program Population-Based Study
Arch Intern Med, September 23, 2002; 162(17): 1985 - 1993.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. I. Li, K. E. Malone, and J. R. Daling
Differences in Breast Cancer Hormone Receptor Status and Histology by Race and Ethnicity among Women 50 Years of Age and Older
Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 601 - 607.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. A. Marchbanks, J. A. McDonald, H. G. Wilson, S. G. Folger, M. G. Mandel, J. R. Daling, L. Bernstein, K. E. Malone, G. Ursin, B. L. Strom, et al.
Oral Contraceptives and the Risk of Breast Cancer
N. Engl. J. Med., June 27, 2002; 346(26): 2025 - 2032.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. B. Bach, D. Schrag, O. W. Brawley, A. Galaznik, S. Yakren, and C. B. Begg
Survival of Blacks and Whites After a Cancer Diagnosis
JAMA, April 24, 2002; 287(16): 2106 - 2113.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
O. W. Brawley
Disaggregating the Effects of Race and Poverty on Breast Cancer Outcomes
J Natl Cancer Inst, April 3, 2002; 94(7): 471 - 473.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
B. A. Miller, B. F. Hankey, and T. L. Thomas
Impact of Sociodemographic Factors, Hormone Receptor Status, and Tumor Grade on Ethnic Differences in Tumor Stage and Size for Breast Cancer in US Women
Am. J. Epidemiol., March 15, 2002; 155(6): 534 - 545.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. J. Dignam
Efficacy of Systemic Adjuvant Therapy for Breast Cancer in African-American and Caucasian Women
J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 36 - 43.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. J. Dignam, L. Colangelo, W. Tian, J. Jones, R. Smith, D. L. Wickerham, and N. Wolmark
Outcomes Among African-Americans and Caucasians in Colon Cancer Adjuvant Therapy Trials: Findings From the National Surgical Adjuvant Breast and Bowel Project
J Natl Cancer Inst, November 17, 1999; 91(22): 1933 - 1940.
[Abstract] [Full Text] [PDF]


Home page
Arch Fam MedHome page
K. C. Chu, R. E. Tarone, and O. W. Brawley
Breast Cancer Trends of Black Women Compared With White Women
Arch Fam Med, November 1, 1999; 8(6): 521 - 528.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. U. Yood, C. C. Johnson, A. Blount, J. Abrams, E. Wolman, B. D. McCarthy, U. Raju, D. S. Nathanson, M. Worsham, and S. R. Wolman
Race and Differences in Breast Cancer Survival in a Managed Care Population
J Natl Cancer Inst, September 1, 1999; 91(17): 1487 - 1491.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. R. Lannin, H. F. Mathews, J. Mitchell, M. S. Swanson, F. H. Swanson, and M. S. Edwards
Influence of Socioeconomic and Cultural Factors on Racial Differences in Late-Stage Presentation of Breast Cancer
JAMA, June 10, 1998; 279(22): 1801 - 1807.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.